U.S. federal trademark · Serial No. 86927393 · Reg. No. VR201601220
[ Vaccines; ] pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of [ Alzheimer's disease and disorder, stroke, ] depression, cognitive disorders, mood disorders [, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes; pharmaceuticals for treatment of cognitive disorders and diseases; all of the foregoing comprising or containing vortioxetine ]
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.